Harvard Bioscience Announces Fourth Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- Wall Street ends down as oil prices, Treasury yields rise
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil settles up around 4% as Iran's president vows to never surrender
- Wall Street ends down as oil prices, Treasury yields rise
- Anthropic's Claude AI identifies novel enzyme system in DNA search
- AppLovin (APP) on watch amid 3% drop premarket as boutique comments circulate
- Plug Power COO resigns to join another company
- Xtend AI Robotics wins Phase III of USSOCOM lethal drone program
Harvard Bioscience (HBIO) Reports Q4 EPS of $0.02
March 8, 2022 7:08 AM ESTHarvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of $0.02, versus ($0.02) reported last year. Revenue for the quarter came in at $33.1 million, versus $31 million reported last year.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
... More